Synonyms:aminoglutethimide, 125-84-8, dl-Aminoglutethimide, Cytadren, Orimeten, p-Aminoglutethimide, Elipten, 3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione, 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione, 2-(p-Aminophenyl)-2-ethylglutarimide, Aminoglutetimida, 2,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl-, Aminoglutethimidum, Ba-16038, 3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine, (+/-)-p-AMINOGLUTETHIMIDE, NSC-330915, Glutethimide, para-amino, AG-1, 3-(4-aminophenyl)-3-ethyl-piperidine-2,6-dione, Glutarimide, 2-(p-aminophenyl)-2-ethyl-, MFCD00010122, CHEMBL488, CHEBI:2654, alpha-(p-Aminophenyl)-alpha-ethylglutarimide, DTXSID8022589, 0O54ZQ14I9, .alpha.-(p-Aminophenyl)-.alpha.-ethylglutarimide, (RS)-2-(4-Amino-phenyl)-2-ethyl-glutarimide;(RS)-3-(4-Amino-phenyl)-3-ethyl-2,6-dioxo-piperidine, DTXCID202589, Aminoglutethimidum [INN-Latin], Aminoglutetimida [INN-Spanish], Aminoglutetimide, Ba 16038, Cytadren (TN), SMR000326785, C 16038-BA, CCRIS 7562, aminoglutethimide (AG), SR-01000075596, 3-(4-Aminophenyl)-3-ethyl-2,6-piperidindion, EINECS 204-756-4, BRN 0210656, Aminoglutethimide (USP/INN), UNII-0O54ZQ14I9, HSDB 7494, Aminoglutethimide [USP:INN:BAN], NCGC00016379-01, CAS-125-84-8, Prestwick_243, Spectrum_000040, (y)-p-Aminoglutethimide, Aminoglutethimide AG, 4, Aminoglutethimide- Bio-X, (?)-p-Aminoglutethimide, Prestwick0_000244, Prestwick1_000244, Prestwick2_000244, Prestwick3_000244, Spectrum2_000093, Spectrum3_000296, Spectrum4_000144, Spectrum5_000802, A 9657, SCHEMBL4306, Aminoglutethimide (Cytadren), Lopac0_000124, BSPBio_000028, BSPBio_001832, KBioGR_000588, KBioSS_000400, (A+/-)-p-Aminoglutethimide, MLS000859924, MLS001213216, AMINOGLUTETHIMIDE [MI], DivK1c_000884, SPECTRUM1500115, SPBio_000046, SPBio_002247, AMINOGLUTETHIMIDE [INN], BDBM9460, BPBio1_000032, GTPL7054, AMINOGLUTETHIMIDE [HSDB], AMINOGLUTETHIMIDE [VANDF], HMS502M06, KBio1_000884, KBio2_000400, KBio2_002968, KBio2_005536, KBio3_001332, AMINOGLUTETHIMIDE [MART.], NINDS_000884, AMINOGLUTETHIMIDE [WHO-DD], HMS1568B10, HMS1920C09, HMS2090I05, HMS2091I09, HMS2095B10, HMS2231M19, HMS3259H10, HMS3260I10, HMS3372M07, HMS3655O17, HMS3712B10, Pharmakon1600-01500115, AMY33415, BCP28501, HY-B0237, 2, 3-(4-aminophenyl)-3-ethyl-, Tox21_110406, Tox21_303497, Tox21_500124, BBL010961, CCG-38911, NSC330915, NSC755868, STK802074, AKOS004120070, AKOS022060651, Tox21_110406_1, AMINOGLUTETHIMIDE [EP IMPURITY], AMINOGLUTETHIMIDE [ORANGE BOOK], DB00357, LP00124, NC00714, NSC 330915, NSC 755868, NSC-755868, PB48252, SDCCGSBI-0050112.P005, AMINOGLUTETHIMIDE [EP MONOGRAPH], AMINOGLUTETHIMIDE [USP IMPURITY], IDI1_000884, SMP1_000017, NCGC00015110-02, NCGC00015110-03, NCGC00015110-04, NCGC00015110-05, NCGC00015110-06, NCGC00015110-07, NCGC00015110-09, NCGC00015110-12, NCGC00015110-21, NCGC00093615-01, NCGC00093615-02, NCGC00093615-03, NCGC00093615-04, NCGC00093615-05, NCGC00257263-01, NCGC00260809-01, AC-12456, AS-13282, BA164155, NCI60_002900, SBI-0050112.P004, DB-021640, DB-072002, DB-072275, 3-Carboxy-1,1-dimethyl-, (E)-2-propenyl, AB00051935, EU-0100124, FT-0773944, S1672, SW196550-3, ( inverted question mark)-p-Aminoglutethimide, EN300-53368, VU0243029-3, C07617, D00574, D88489, AB00051935-09, AB00051935-11, AB00051935_12, AB00051935_13, A805433, Q241150, SR-01000075596-1, SR-01000075596-4, SR-01000075596-6, W-108399, BRD-A25234499-001-05-0, BRD-A25234499-001-09-2, Z800191876, Aminoglutethimide, European Pharmacopoeia (EP) Reference Standard, Aminoglutethimide, United States Pharmacopeia (USP) Reference Standard
Pubchem:PUBCHEM:2145
Id:679fdd16-a521-56ee-9ed3-d289e3706a89
Description:nan
